Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/APO2L) and its receptors expression in human squamous cell carcinoma of the oral cavity

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1113-1119

  Fukuda, Masakatsu ^a   Hamao, Aya ^a   Tanaka, Akio ^a   Kitada, Munenori ^a   Suzuki, Seiji ^a   Kusama, Kaoru ^a   Sakashita, Hideaki ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Apoptosis; Confocal laser microscopy; Human oral squamous cell carcinoma; Monoclonal anti TRAIL antibody; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; COLORING AGENT; MEMBRANE PROTEIN; MESSENGER RNA; RNA; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TNFRSF10A PROTEIN, HUMAN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; CONFOCAL MICROSCOPY; DOSE RESPONSE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUTH TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MOUTH NEOPLASMS; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2142686111     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.5.1113     Document Type: Article

References (30)

1. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A and Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687-12690, 1996. (Pubitemid 26175834)
2. Wiley SR, Schooley K, Smolak PJ, et al: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682, 1995. (Pubitemid 26091143)
3. Degli-Esposti MA, Smolak PJ, Walczak H, et al: Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186: 1165-1170, 1997. (Pubitemid 27441160)
4. Pan G, Ni J, Wei YF, Yu G, Gentz R and Dixit VM: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815-818, 1997. (Pubitemid 27366732)
5. Sheridan JP, Marsters SA, Pitti RM, et al: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818-821, 1997. (Pubitemid 27366733)
6. Marsters SA, Sheridan JP, Pitti RM, et al: A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol 7: 1003-1006, 1997. (Pubitemid 28017080)
7. Pan G, Ni J, Yu G, Wei YF and Dixit VM: TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signaling. FEBS Lett 424: 41-45, 1998. (Pubitemid 28130348)
8. Griffith TS, Rauch CT, Smolak PJ, et al: Functional analysis of TRAIL receptors using monoclonal antibodies. J Immunol 162: 2597-2605, 1999. (Pubitemid 29309279)
9. Rieger J, Naumann U, Glaser T, Ashkenazi A and Weller M: APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett 427: 124-128, 1998. (Pubitemid 28210109)
10. Marsters SA, Pitti RM, Donahue CJ, Ruppert S, Bauer KD and Ashkenazi A: Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr Biol 6: 750-752, 1996. (Pubitemid 126656342)
11. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
12. Pindborg JJ, Reichart PA, Smith CJ and van Der Waal I: Histological typing of cancer and precancer of the oral mucosa. In: World Health Organization International Histological Classification of Tumors (2nd edition). Springer-Verlag Berlin Heidelberg (ed). New York, 1997.
13. Shi SR, Key ME and Kalra KL: Antigen retrieval in formalin-fixed and paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991.
14. Jacobson MD, Weil M and Raff MC: Programmed cell death in animal development. Cell 88: 347-354, 1997. (Pubitemid 27131376)
15. Nagata S: Apoptosis by death factor. Cell 88: 355-365, 1997.
16. Nagata S and Golstein P: The Fas death factor. Science 267: 1449-1456, 1995.
17. Suda T, Okazaki T, Naito Y, et al: Expression of the Fas ligand in cells of T cell lineage. J Immunol 154: 3806-3813, 1995.
18. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR and Strom SC: Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6: 564-567, 2000. (Pubitemid 30305907)
19. Strand S, Hofmann WJ, Hug H, et al: Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: a mechanism of immune evasion? Nat Med 2: 1361-1366, 1996.
20. Hahne M, Rimoldi D, Schroter M, et al: Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274: 1363-1366, 1996. (Pubitemid 26391458)
21. Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P and Ohgaki H: Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer. Cancer Res 58: 2057-2062, 1998. (Pubitemid 28232883)
22. Keane MM, Ettenberg SA, Nau MM, Russell EK and Lipkowitz S: Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 59: 734-741, 1999. (Pubitemid 29076075)
23. Wen J, Ramadevi N, Nguyen D, Perkins C, Worthington E and Bhalla K: Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. Blood 96: 3900-3906, 2000.
24. Knight MJ, Riffkin CD, Muscat AM, Ashley DM and Hawkins CJ: Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. Oncogene 20: 5789-5798, 2001. (Pubitemid 32937948)
25. Pai SI, Wu GS, Özören N, Wu L, Jen J, Sidransky D and El-Deiry WS: Rare loss-of-function mutation of a death receptor gene in head and neck cancer. Cancer Res 58: 3513-3518, 1998. (Pubitemid 28376541)
26. Fisher MJ, Virmani AK, Wu L, et al: Nucleotide substitution in the Ectodomain of TRAIL receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res 7: 1688-1697, 2001. (Pubitemid 32708637)
27. Scaffidi C, Kirchhoff S, Krammer PH and Peter ME: Apoptosis signaling in lymphocytes. Curr Opin Immunol 11: 277-285, 1999.
28. Nakamura M, Rieger J, Weiler M, Kim J, Kleihues P and Ohgaki H: APO2L/TRAIL expression in human brain tumors. Acta Neuropathol 99: 1-6, 2000. (Pubitemid 30093431)
29. Matsuzaki H, Schmied BM, Ulrich A, et al: Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells. Clin Cancer Res 7: 407-414, 2001. (Pubitemid 32183046)
30. Mitsiades CS, Treon SP, Mitsiades N, et al: TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. Blood 98: 795-804, 2001.